Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Universal Donor Expanded Tgf-Beta-Imprinted Nk Cells
Her2-Receptor Negative Breast Cancer
Margaret Gatti-Mays
P1/2
CC
(47)
Uromitexan
Metastatic Prostate Carcinoma
CuraCell TX AB
P1/2
CC
(47)
Valemetostat
Head And Neck Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Valemetostat
Non-Hodgkin Lymphoma
Celgene
P1/2
CC
(47)
vb15010
Prostate Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
P1/2
CC
(47)
Veliparib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(47)
Vgn-R08B
Parkinson Disease
Shanghai Vitalgen BioPharma Co., Ltd.
P1/2
CC
(47)
Vls-1488
Ovarian Serous Adenocarcinoma
Volastra Therapeutics, Inc.
P1/2
CC
(47)
Vmd-102
Non-Small Cell Lung Carcinoma
VM Discovery, Inc.
P1/2
CC
(47)
Vofatamab
Urinary Bladder Carcinoma
Fusion Pharmaceuticals Inc.
P1/2
CC
(47)
Vorolanib
Kidney Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(47)
Wve-007
Obesity Disorder
Wave Life Sciences USA, Inc.
P1/2
CC
(47)
Xer-001
Pancreatic Ductal Adenocarcinoma
Xerient Pharma
P1/2
CC
(47)
xnw27011
Gastric Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(47)
xnw28012
Cervical Cancer
Evopoint Biosciences Inc.
P1/2
CC
(47)
xnw5004
Castration-Resistant Prostate Carcinoma
Evopoint Biosciences Inc.
P1/2
CC
(47)
xs005
Neoplasm
Dushu Lake Hospital Affiliated to Soochow University
P1/2
CC
(47)
XYA02
Gastroesophageal Junction Adenocarcinoma
XYone Therapeutics, Inc
P1/2
CC
(47)
Xzp-5955 Tablets
Non-Small Cell Lung Carcinoma
Xuanzhu Biopharmaceutical Co., Ltd.
P1/2
CC
(47)
Zeprumetostat
Extranodal Nasal NK/T Cell Lymphoma
Rong Tao
P1/2
CC
(47)
Zongertinib
Colorectal Cancer
Boehringer Ingelheim
P1/2
CC
(47)
4scar-psma t cells
Neoplasm
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(46)
a2b543
Non-Small Cell Squamous Lung Carcinoma
A2 Biotherapeutics Inc.
P1/2
CC
(46)
Abemaciclib
Central Nervous System Neoplasm
Stemline Therapeutics, Inc.
P1/2
CC
(46)
Abemaciclib
Malignant Colon Neoplasm
M.D. Anderson Cancer Center
P1/2
CC
(46)
Showing 3126 to 3150 of 6,302 assets
Previous
Page 126 of 253
Next